These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8673864)

  • 1. Beta-2-microglobulin in diseases with high bone remodeling.
    Ripoll E; Arribas I; Relea P; Varela L; Villa LF; Revilla M; Rico H
    Calcif Tissue Int; 1995 Oct; 57(4):272-6. PubMed ID: 8673864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Wilczek H
    Cas Lek Cesk; 1997 Dec; 136(23):730-2. PubMed ID: 9476376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta 2-Microglobulin in Paget's bone disease.
    Rico H; Ripoll E; Arribas I; Revilla M; Relea P; Villa LF; de Buergo MA
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
    Ripoll E; Revilla M; Hernández ER; Arribas I; Villa LF; Rico H
    Eur J Clin Invest; 1996 Aug; 26(8):681-5. PubMed ID: 8872064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases.
    Braga V; Dorizzi R; Brocco G; Rossini M; Zamberlan N; Gatti D; Adami S
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):433-9. PubMed ID: 7548450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover.
    Scarnecchia L; Minisola S; Pacitti MT; Carnevale V; Romagnoli E; Rosso R; Mazzuoli GF
    Scand J Clin Lab Invest; 1991 Oct; 51(6):517-24. PubMed ID: 1767245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin does not behave as a biological marker of bone remodeling in patients with primary hyperparathyroidism.
    Broulik PD; Stepán JJ; Haas T
    Clin Chim Acta; 1998 Nov; 278(1):61-6. PubMed ID: 9877125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic-dependent increase of serum beta 2-microglobulin levels in patients with Paget's disease of bone.
    Fiore CE; Foti R; Tamburino C
    Horm Metab Res; 1992 Mar; 24(3):143-4. PubMed ID: 1577406
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
    Torres R; de la Piedra C; Rapado A
    Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-microglobulin in postmenopausal osteoporosis.
    Rico H; Ripoll E; Revilla M; Relea P; Villa LF
    Calcif Tissue Int; 1993 Aug; 53(2):78-80. PubMed ID: 8402325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E; Meunier PJ
    Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
    Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G
    Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.
    Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT
    Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.